![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | A61K 31/51 | (2006.01) |
A61K 31/517 | (2006.01) | ||
A61K 31/535 | (2006.01) | ||
C07D 403/00 | (2006.01) | ||
C07D 239/82 | (2006.01) |
(11) | Number of the document | 1660090 |
(13) | Kind of document | T |
(96) | European patent application number | 04780990.0 |
Date of filing the European patent application | 2004-08-10 | |
(97) | Date of publication of the European application | 2006-05-31 |
(45) | Date of publication and mention of the grant of the patent | 2012-11-21 |
(46) | Date of publication of the claims translation | 2013-03-25 |
(86) | Number | PCT/US2004/026235 |
Date | 2004-08-10 |
(87) | Number | WO 2005/016346 |
Date | 2005-02-24 |
(30) | Number | Date | Country code |
642440 | 2003-08-14 | US | |
551718 P | 2004-03-10 | US |
(72) |
WALLACE, Eli, US
TOPALOV, George, US
LYSSIKATOS, Joseph, US
BUCKMELTER, Alexandre, US
ZHAO, Qian, US
|
(73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Chinazolino analogai, kaip receptoriaus tirozinkinazės inhibitoriai |
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS |
Payment date | Validity (years) | Amount | |
2023-07-20 | 347.00 EUR |